CN109793867A - 降脂降压药茶 - Google Patents
降脂降压药茶 Download PDFInfo
- Publication number
- CN109793867A CN109793867A CN201711120133.2A CN201711120133A CN109793867A CN 109793867 A CN109793867 A CN 109793867A CN 201711120133 A CN201711120133 A CN 201711120133A CN 109793867 A CN109793867 A CN 109793867A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- radix
- medicinal herb
- decreasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 101
- 239000008280 blood Substances 0.000 title claims abstract description 101
- 241001122767 Theaceae Species 0.000 title description 29
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 32
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 18
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 16
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 11
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 11
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 10
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 10
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 10
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000893536 Epimedium Species 0.000 claims abstract description 9
- 235000018905 epimedium Nutrition 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 241000255791 Bombyx Species 0.000 claims abstract description 8
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 230000006837 decompression Effects 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 244000062995 Cassia occidentalis Species 0.000 claims abstract description 6
- 235000001948 Cassia occidentalis Nutrition 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 4
- 239000000835 fiber Substances 0.000 claims abstract description 4
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims abstract 10
- 238000012216 screening Methods 0.000 claims abstract 2
- 239000000796 flavoring agent Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 244000111489 Gardenia augusta Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000151 deposition Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 40
- 210000000952 spleen Anatomy 0.000 abstract description 36
- 210000004072 lung Anatomy 0.000 abstract description 23
- 210000003734 kidney Anatomy 0.000 abstract description 21
- 210000002784 stomach Anatomy 0.000 abstract description 20
- 206010011224 Cough Diseases 0.000 abstract description 10
- 208000004880 Polyuria Diseases 0.000 abstract description 9
- 230000001914 calming effect Effects 0.000 abstract description 9
- 208000006673 asthma Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 210000004204 blood vessel Anatomy 0.000 abstract description 7
- 230000036770 blood supply Effects 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 206010036790 Productive cough Diseases 0.000 abstract description 5
- 210000003802 sputum Anatomy 0.000 abstract description 5
- 208000024794 sputum Diseases 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 244000179560 Prunella vulgaris Species 0.000 abstract description 3
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract description 3
- 230000000747 cardiac effect Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 108700012359 toxins Proteins 0.000 abstract description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 238000003672 processing method Methods 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 31
- 235000019634 flavors Nutrition 0.000 description 27
- 210000002216 heart Anatomy 0.000 description 26
- 206010020772 Hypertension Diseases 0.000 description 23
- 230000007812 deficiency Effects 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 19
- 240000004371 Panax ginseng Species 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 18
- 230000036772 blood pressure Effects 0.000 description 17
- 208000002173 dizziness Diseases 0.000 description 16
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 206010019233 Headaches Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 150000007949 saponins Chemical class 0.000 description 9
- 241001065361 Gynostemma Species 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 229930182490 saponin Natural products 0.000 description 8
- 235000017709 saponins Nutrition 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 229930182478 glucoside Natural products 0.000 description 7
- 150000008131 glucosides Chemical class 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 240000001972 Gardenia jasminoides Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000010415 tropism Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000242 Abortion threatened Diseases 0.000 description 3
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 3
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000005985 Threatened Abortion Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- 240000001341 Reynoutria japonica Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 238000003723 Smelting Methods 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- -1 arasaponin Chemical class 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000005907 cancer growth Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000012866 low blood pressure Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-JGVFFNPUSA-N (1r,5s)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-one Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2=O IECBDTGWSQNQID-JGVFFNPUSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- IECBDTGWSQNQID-UHFFFAOYSA-N Chrysanthenon Natural products CC1=CCC2C(C)(C)C1C2=O IECBDTGWSQNQID-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-SFYZADRCSA-N Chrysanthenone Natural products CC1=CC[C@H]2C(C)(C)[C@@H]1C2=O IECBDTGWSQNQID-SFYZADRCSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 240000008375 Hymenaea courbaril Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001646834 Mesona Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- JJMLQAVFDJXJAL-AWZCNKNJSA-N Pyrethrosin Chemical compound CC(=O)O[C@@H]1\C=C(C)\CC[C@H]2O[C@]2(C)C[C@@H]2OC(=O)C(=C)[C@@H]12 JJMLQAVFDJXJAL-AWZCNKNJSA-N 0.000 description 1
- 241000219287 Saponaria Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000157352 Uncaria Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- QBYFCXBVWQQXFH-UHFFFAOYSA-N acaciin Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4OC6OCC(O)C(O)C6O)cc3O2 QBYFCXBVWQQXFH-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 201000009939 hypertensive encephalopathy Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及到降脂降压药茶的及其制备方法:由以下重量份计的原料组成。绞股蓝、灵芝、黄芪、西洋参、制首乌、川芎、丹参、三七、炒枣仁、炒山药、草决明、粉葛根、砂仁、炒白术、茯苓、炒意仁、天麻、炒僵蚕、勾藤,罗卜麻、夏枯草、石斛、炒东楂、银杏叶、野菊花、桅枝、人参、杭菊、淫阳霍,其制备方法为;1、筛选纯净原料备用2、药物烘干加工炮制3、混合药物过筛后的密闭备用4、药茶的分发包装制备。本发明具有对五脏六府综的合调理、而具有强心安神、补气养血、滋阴舒肝理气、平肝替阳护肝健脾、益气养胃除湿化痰、润肺止咳平喘,活血化瘀消除血管垃圾毒素,补肾利尿提高自身免疫力,而有效的控制血脂血糖、平稳降压确保心脑供血。
Description
降脂降压药茶
一、技术领域:本发明涉及中药散剂加工领域里的一种新配方组合而成。具体实施涉及到“降脂降压药茶”的确切疗效与制备方法。
二、背景技术:高血压多为急慢性发作的常见病:包括高血圧脑病、脑出血、脑梗塞、脑血管急发堵塞、以后会出现心肌猝死,慢性脑中风偏瘫、口眼歪斜、半身不遂。而高血压引发心梗时,因起病比较快、不容易早发现,因此血压随着情志而变化,时高时低,加上患者意识差,因而不被广大患者所重视,以为治不治无所为,一但服药就甩不掉药罐子的模糊认识,从而错过了治疗的最佳时机。
三、发明内容:针对现有技术上存在的不足,本发明的目标能够提供一种老经验、新方案、新配方。“降脂降压药茶”具有特效的降脂、降压、稳血糖的作用,为什么能控降三高?首先采取强心安神、心不慌、睡眠好、血压下降、清肝泻火、平肝潜阳降压、通过活血化瘀、清除血管垃圾毒素来降压、降脂,健脾利湿、利尿、来降脂压,清热润肺、止咳化痰、痰調气顺、来降脂降压,用补气摄肝肾之火控降压,再用补肾纳气、提高自身免疫功能去稳降三高,血压、血脂、胆固醇,及血糖等。三高症,中医强调治未病“未病先防”,“既病防变”“瘥后防复的原理”在益气养血、人生于血管畅通、成长于动脉硬化、衰老于供血不足、死于血管堵塞、在脑心同治的基础上“衰老供血不足乃万病之源”的新学说、新概念。“降脂降压药茶”唯有独特、双项供血的疗效,脑心同治才能控防心、脑并发症。
降脂降压药茶服用方便,只用保温杯开水冲泡服用即可,不用煎药、省时省力,减少经费,上飞机坐轮船、乘坐火车携带方便,串门会友以药代茶,既渴茶、又保健、既降脂压、又稳控血糖,既能治病、又能防病,利国、利民,填补了西药能治不能防的弊瑞。
目前、高血压是危害健康的最主要因素,因此发病率高、致残、致死率高,当前已成为一个较严重的社会问题。而且高血压呈年轻化趋势,中国疾病防控中心公布数据显示、我国十五岁以上人群高血压患病率为24%全国高血压患者人数为2.66亿、每五个成年人中致少有一人患高血压,儿童、青少年血压偏高的比例已达15%左右。在上班组人群中工作忙、压力大、学生作业量大、学***均寿命、劳动力人数的下降造成影响,所以必須引起中国疾控中心的高度重视。目前降压西药能治不能控防,冶标不冶本,高血压患者大把吃药、对肝、肾、胃损害极大,不吃又不行。经我诊疗的有三十九、四十一岁的青状年患高血压长年服西药,他爱人讲、我老公一年前肾功能的***都不起作用了,很苦恼,也无奈。
具体实施方式
本发明的技术方案是这样实现的,实施例1:一种新配方仝氏健安降脂降压药茶,由下列重量份的药物加工制成的:绞股兰13~16份、木灵芝12~16份、西洋参10~16份、黄芪12~16份、制首乌10~16份、川芎10~16份、丹参8~12份、三七参8~12份、炒枣仁 6~10份,炒山药10~16份、草决明6-10份、粉葛根10-16份、砂仁6-12份、炒白术10~ 16份、茯苓6~12份、炒薏仁6~12份、天麻6~12份、炒僵蚕6~10份、勾滕6~12份,罗卜麻8~12份、夏枯草球6~12份、霍山石斛6~12份、银杏叶6~10份、焦三楂10~12 份、野菊花6~12份、栀枝6~10份、人参8~12份、杭菊花6~12份、淫阳霍6-12份。
实施例2:一种新配方仝氏健安降脂降压药茶,它是由下列重量份的药物加工制成的。
仝氏健安降脂降压药茶,制备方法包括以下步骤:
【1】筛选无霉烂、无变质、色泽纯正的。
绞股兰12份、灵芝10份、黄芪10、西洋参8份、制首乌8份、川芎7份、丹参6份、三七参7份、炒枣仁6份、炒山药7份、草决明5份、粉葛根7份、砂仁6伤、炒白术7份、茯苓6份、炒薏米6份、天麻6份、炒僵蚕5份、勾藤5份、罗卜麻叶6份、夏枯球6份、霍山石斛5份、炒东楂7份、银杏叶6份、野菊花5份、栀枝5份,人参8份、杭菊5份、淫阳霍5份,备用。
【2】:将1中所述的原材料中的绞股兰、木灵芝、黄芪、西洋参、制首乌、川芎、丹参、三七参、炒枣仁、炒山药、草决明、粉葛根、砂仁、炒白术、茯苓、炒薏仁、天麻、炒僵蚕、勾藤、罗卜麻、夏枯草球、霍山石斛、炒东楂、银杏叶、野菊花、栀枝、人参、杭菊、淫阳霍等,按照以上所述的重量份的配比掺合在一起、在用电烤箱低温烘干后、用粉碎机进行粉碎、用200-300目筛,得到的混合药粉备用。按照权利要求1.2所述的原材料中的绞股兰、木灵芝、黄芪、西洋参、制首乌、川芎、丹参、三七参、炒枣仁、炒山药、草决明、粉葛根、砂仁、炒白术茯苓、炒薏仁、天麻、炒僵蚕、勾藤、罗卜麻、夏枯草球、霍山石斛、炒东楂、银杏叶、野菊花、栀枝、人参、杭菊、淫阳霍等,按照以上重量份配比混合在一起用电烤箱低温烘干用粉机粉碎,在用200~300目筛选得到的混合药粉备用。
仝氏健安降脂降压药茶的使用方法如下,用重量份配比制成的混合药粉、然后分装制成药袋、按中药散剂分装制成散剂药茶袋、每日早晚用保温杯开水冲服即可、煎几分钟更好。孕妇及脾胃虚寒者禁服1号药茶。
二、所述1-2以上每味药物的、性味、功效、与主治,的科学分析。参照中华人民共和国药典,1990年版第一部查阅第4页、7页、20、28、44、62、75、84,120,149,183,203、 216,218,227,251、272、274、280、291、299、325、335、339页。上述其中绞股兰、西洋参、银杏叶,参照江苏.科学技术出版2002年11月第一版查阅,所述、药物成份及含量参照江苏科学技术出版社2002年第一版,单方大全,及人民军医出版社出版2002年6月第二版,第一次印刷、一味中药袪顽疾。
【1绞股兰】:味苦、甘、性寒。归脾、肺经。具有健脾益气、生津止渴,清热解毒,止咳祛痰等作用。适用于脾胃气虚气阴两伤所致的胃脘疼痛,形瘦乏力口渴等,血小板减少,冠心病,消化姓溃疡慢性胃炎等多种疾患。常用量15~30克水煎服或研未吞服,每次3~6克亦可泡茶服。
【2灵芝】味甘、微苦,性平。主归心、肾、肺经。具有益气补虚,养心安神、止咳平喘等作用。主治心气不足或心脾两虚所致的心悸怔忡、失眠多梦、健忘、神疲体倦、食欲不振,或肺虚久咳气喘及一切虚劳体弱、年老体衰之证。常服能促进脏腑的生理机能,增强体质,延年益寿,所以曾有“仙草”的美誉。常用3~15克。水煎服;研未内服,1.5~3克每天2~ 3次;外用适量。
【3黄芪】[性味]甘温。归肺,脾经。[功能与主治]补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿痈疽难溃,,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。密制黄芪益气补中。用于气虚乏力,食少便溏。【用量9~30克】
【4西洋参】味苦、微甘,性寒。归心肺肾经、具有补气养阴扶正,清火、生津之功。适用于阴虚火旺、咳嗽气喘、痰中带血,或气阴两伤,,倦怠乏力,口渴欲饮,或津液不足,口干舌燥者肺虚潮热盗汗肾虚头晕,肝虚贫血、中气不足。西洋参为清补之品,与性温的人参相比,它的寒凉之性刚好弥补了人参性温偏燥的不足,体现了自己的特色。常用量为3~5克、另煎取汁服,均可。
【5制何首乌】[性味与归经]苦、干、涩、温。归肝、心、肾经。[功能与主治]补肝肾,益精血,乌须发,强筋骨。用于血虚萎黄,眩晕耳鸣,须发早白,,腰膝酸软,肢体麻木,崩漏带下,久疟体虚;高血脂症、【用量6~12克】
【6川芎】【性味与归经】辛、温。归肝、胆,心包经。【功能与主治】活血行气,祛风止痛。用于月经不凋,经闭痛经,卫瘕腹痛,胸胁刺痛、跌扑肿痛、头痛,风湿痹痛。[用量3~9克。
【7丹参】【性味】苦,微寒。归心、肝经。【功能与主治】祛瘀止痛,活血通经,清心除烦。用于***,经闭痛经,徵瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。【用量9~15克】。
【8三七】性味】甘、徵苦,归肝、胃经。【功能】散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,,崩漏,外伤出血,胸腹刺痛,,跌扑肿痛。具有降压降脂抗癌提高心肌供氧能力增强机体免疫功能。含三七皂代人参皂苷等多种活性物质,具有清热平肝降压排毒养颜、减肥、防癌抗癌,提神补气之功效。用量3~9克:研粉吞服;每次1~3克;外用适量。。孕妇慎用。
【9炒枣仁】【性味】甘、酸,平。归肝、胆、心经。【功能与主治】补肝,宁心,敛汗,生津。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。用量9~15克
【10山药】【味甘,平。】归脾、肺、肾经。【功能与主治】
补脾养胃,生津益肺。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒补脾健胃。用于脾虚食少,泄泻便溏,白带过多、用量15~30克。
【11决明子】【性味】甘、苦、咸,微寒。归肝、大肠经。【功能与主治】清热明目,润肠通便。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。【用量9-15克
【12葛根】性味。甘、辛,凉。归脾,胃经。【功能与主治】解肌退热,,生津,透疹,升阳止泻。用于外感发热头痛,项强消渴,,麻疹不透,,热痢,泄泻:高血压颈项痛。
现代可用于治疗高血压、脑血管疾病,对改善头痛,眩晕、项强、耳鸣肢体麻木、心绞痛等症状有效。常用量为9~15克。
【13砂仁】【性味辛,温。归脾、胃、肾经。【功能与主治】化湿开胃,温脾止泻,理气安胎。用于湿浊中阻,脘痞不饥,脾胃虚寒,呕吐泄泻,妊娠恶殂,胎动不安。【用量3~10克入煎后下。
【14炒白术】性味与归经苦、甘,温。归脾,胃经。功效与主治。健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,,胎动不安。土白术健脾,和胃,,安胎。用于脾虚食少,泄泻便溏,胎动不安。用量6~15克。
【15茯苓】性味甘、淡,平。归心、肺、脾、肾经。【功能与主治】利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,,便溏泄泻,心神不安,惊悸失眠。【用量9~15克】
【16薏仁】【性味】甘、淡,凉。无毒。归脾、胄、肾三经。【功能与主治】健脾渗湿,除痹止泻,清热排脓。用于水肿,脚气,小便不利,湿痹拘挛,脾虚泄泻,肺痈,肠痈;扁平疣。【用量9-30克】
【17天麻】性味甘、平,归肝经。’【功能与主治】平肝息风止痉。用于头痛眩晕,肢体麻木,小儿惊风,癫痫抽搐,破伤风症。用量3~9克。
【18僵蚕】性味成、辛、平。归肝、肺、胃经。功能与主治。祛风定惊,化痰散结。用于惊风抽搐,,咽喉肿痛,颌下***炎,面神经麻痹,皮肤瘙痒。用量5~9克。
【19钩藤】性味甘,凉。归肝、心包经。【功能与主治】清热平肝,息风定惊用于头痛眩晕,感冒夹惊,惊痫抽搐,妊娠子痫;高血压症。【用量3~15克。
【20罗卜麻叶】性味、甘、苦,凉。归肝经。【功能与主治】平肝安神,清热利水。用于肝阳眩晕,心悸失眠,浮肿尿少;高血压病。以及神经衰弱,肾炎浮肿。用量6~12克
【21夏枯球】性味、辛、苦,寒。归肝、胆经。【功能与主治】清火明目,散结,消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬瘿瘤,乳痈肿痛,甲状腺肿大,***结核,乳腺增生,高血压症。用量9~15克
【22霍石斛】性味甘微寒。归胃、肾经【功能与主治】、益胃生津、滋阴清热、用于阴伤津亏。口干烦食少干呕、病后虚热、目暗不明、1兹养阴津、2增强体质、3补益脾胃、4护肝利胆、5强筋降脂、6降低血瑭、7抑制肿瘤、8兹养肌肤。用量6-12克
【23炒东楂】【性味与归经】酸、甘、微温。归脾,胃,肝经。【功能与主治】。消食健胃,行气散瘀。用于肉食积滞,胃脘胀满,泻痢腹痛、瘀血经闭,产后瘀阻,心腹刺痛,疝气疼痛;高血脂症。焦山楂消食导滞作用增强,泻痢不爽【用量】9~12克。
【24银杏叶】:性味、甘、苦、涩,性平。归肺。具有敛肺、平喘、止痛的作用。。用于肺虚咳喘以及高血脂、高血压、冠心病、心绞痛及脑血管痉挛。扩冠降脂,治疗冠状动脉粥样硬化心脏病。
【25野菊花】性味苦、辛,微寒。归肝、心经。[功效与主治]清热解毒。用与疔疮痈肿,目赤肿痛,头痛眩晕。用量9~15克
【26栀子】:性味,苦,寒。归心、肺、三焦经。功能与主治,泻火除烦,清热利尿,凉血解毒。用于热病心烦,黄疸尿赤,血淋涩痛,血热吐衄,目赤肿痛,火毒疮疡;外治扭挫伤痛。焦栀子凉血止血。用于血热吐,、尿血崩漏。用量6~9克【注解】所述1.以上26味为仝氏春夏清肝一号药茶。所述1.在原有26味仝氏春夏清肝一号药茶的组方上去掉西洋参,野菊花,栀子。再加上下方人参8份,杭白菊5份,淫阳霍5份,【为仝氏秋冬平稳2号药茶】
【27人参】甘、微苦、、平。归脾、肺、心。【功能与主治】大补元气,复脉固脱,补脾益肺,生津,安神。用于体虚欲脱、肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,久病虚。羸羸。惊悸失眠阳痿宫冷:心力衰竭,心原性休克。用量3-9克。现代研究表明,人参含有人参皂甙及挥发油、甾醇、多糖等,能兴奋中枢神经***,增强大脑皮层兴奋过程,尤其能使兴奋过程增强更显著,故有抗疲劳的作用。能增强造血玑能,促进骨髓细胞增殖,使液中红细胞、血红蛋白和白细胞都增加。能使心脏收缩力加强,所以有强心作用。能绛低血糖,呈现出胰岛素样作用。能提高机体适应性增强机体非特异性抵抗力,促进病理过程恢釜正常巩能,,这个作用是向着机体有利方面进行的,如既可使低血压升高,又可使高血压恢复正常有人称之为;适应原样作用。能增强性腺机能,人参虽无性激素样作用,但能兴奋垂体分泌性腺激素,缯强男女的性腺机能。有抗肿瘤作用,曾发现人参具有抑制癌细胞生长的物质,对艾氏腹水癌的生长有抑制作用。
【28白杭菊花】性味甘、苦,微寒。归肺、肝经。【功能与主治】散风清热,平肝明目。用于风热感冒,,头痛眩晕,目赤肿痛,眼目昏花。[用量5-9克]
【29淫阳霍】味辛、甘、性温。归肝肾经。功能与主治,补肾阳,强筋骨,祛风湿。用于阳痿遗精,筋骨痿软,风湿痹痛,麻木佝挛现代研究表明,菊花含有挥发油、腺嘌呤、胆碱、水苏碱、菊甙、龙脑樟脑、菊油环酮、刺槐甙树脂、除虫菊内酯、氨基酸、维生素a及维生素b--维生素乙等。能抗病原微生物、,对多种致病菌及病毒均有一定的拮杭作用。有解热、抗炎作用,能扩张冠脉,减轻心肌缺血状态。此外,尚有抗衰老效应;更年期高血压症。能促进旦白合成,调节细胞代谢,增强免疫抗衰老,抗心肌缺氧及降压。
三、所述以上药物成分含量、性味功效,与主治的针对性,综合分析:
以上二十九味天然中草药含多种皂甙、、即三七皂甙,人参皂甙,灵芝麦角甾醇树脂,胆碱,甘露醇、多糖、维生素c及b组维生素,西洋参所含的总皂甙,山药薯蓣粘液质、皂甙,游离氨基酸、止权素,何首乌所含的恩醌,卵磷脂,天麻含香荚兰醇、皂甙,丹参酮,黄芪甙、三萜甙,栀枝甙,芸香甙及黄酮,人参皂甙挥发油甾醇,多糖,菊花含的挥发油,胆碱,水苏碱,菊甙,刺槐皂树脂,氨基酸,维生素以及黄芩甙汉黄甙,黄芩素等。更精妙的是,每 10克健安茶中黄酮含量高达几百毫克,皂甙含量更高。以上二十九味中所含的有效成份能达到,1、用西洋参补气,养血,养阴扶正清虚火,三七参散瘀止血消肿、活络通经,清除血液垃圾,排出体内毒素,而降脂降压、杭癌、防癌、提神补气之功、而气足才能推动血液循环,气行血才行、气滞血才瘀,瘀血不去、新血不生,气为血之帅,血为气之母。所以气虚不聂肝肾之火,血压才升高,2、用天麻,僵虫息风止痉、平肝潜阳。肝火清血压自然下降,然而血管通、血脂、血压下降。大脑不缺氧,心脏不缺血,不发脑梗及心梗。3、运用白术、茯苓、砂仁、温胃、健脾利湿、利尿、消除水肿及痰饮,用于水肿尿少、湿浊中阻、脾胃虚寒,在舒肝健脾、和胃的基础上、脾胃内不生湿饮、哪里来的痰,4、灵芝、绞股蓝,清热止咳、化痰,润肺平喘。又降气、痰调气顺、“而痰生百病”肺胃无痰饮,气血畅通、胸不闷、气不短,心肌供氧充足,头脑清腥,少发脑梗和心肌梗塞。5、首乌、山药补肾养肝、补脾养胃、利湿,利尿和退虚热消渴、迫使血压下降。6、黄芪,丹参、野菊花补气活血清火,控血糖,血压。7、葛根、银杏叶,山楂、解肌退热、升阳止泻、消食平喘、扩冠降脂,降压。8,枣仁、人参气补,养肝、强心、安神,休息睡眠充足、确保供血,供氧,才能保障心脑健康。
以上总体方案达到了对五脏六腑的相互协调、综合调理,使阴阳气血调节平衡、肠道通、气血通、血管通、经络通。血脂、血压,血糖稳步下降。特别是绞股蓝一味药物中所含有与人参相同的有效成份皂甙最高,故有人把他誉为南方人参。绞股蓝中含有4种与人参有效成分皂甙、相同的物质,绞股蓝所含有的皂甙是长白山人参、高丽参、所含人参的四倍,现代研究表明绞股蓝验出股兰皂甙达八十多种,氨基酸微量元素十八种之多。绞股蓝还含有一种特殊成份,即甘茶曼糖甙,具有滋补消除疲劳、抗炎多种功效。绞股兰是一种新的抗癌药物、对肺癌、肝癌、胃癌、乳腺癌等20多种癌症均有抑制效果、健康人如能长期服用也可减少患癌的危险。再加上配方的几十种中草药有效成份更使疗效倍增、具有平稳降压、降脂、降糖,增强心脑供氧量。舒通冠状动脉和脑血流量,在预防动脉硬化高血压、冠心病以及中风偏瘫、糖尿病以及肥胖症等方面疗效显薯、因此特别适合中老年患者服用,常饮添岁增寿。
四、药物的制备方法及制作程序。
处方中所需要加工炮制的药物、按雷公炮制方法炮制加工,在混合或单味进行低温烘干粉碎成细未过滤200-300目筛细粉后备用。
五、药物的总体功效与主治:
补益气血,养阴,清肝明目、平肝潜阳、养心安神,健脾利湿、补肾益精。活血化瘀消肿止痛。清热解毒、利尿、护肝养胃、消食化滞、益气生津、止咳化痰,润肺平喘、强心安神、降脂、降压、降血糖,促进微循环、通络醒脑等功效。
六、主治,高血压、血脂稠、脑血管硬化,冠心病,心悸烦燥,心梗及血压高引起的半身麻木,口角流涎、语言涩塞、及血栓、引起的头痛、头晕、失眠健忘、记意力减退、大脑迟钝、以及肥胖症带来的高血糖,高血脂以及糖尿引起的***等。
七、用法及用量,血压在95至180左右、用保温杯冲服,或用电锅熬几分钟最好。服用时、始终保持温服。每天冲服二次、每次6克药粉,冲服最后剩余药沫服下。低血压在95高压在 150左右,每天用保温杯冲服【6-7克药粉】多次冲服一天喝完,熬几分钟最好,最后余药沫服下。
八、注意事项,婴幼儿孕妇、哺乳期妇女、血压低、脾虚胃寒者忌用。服药期间禁服油腻、大肉、动物内脏、辣椒、烟酒及生冷蛋类,油炸食物等切忌。
九、病历
病历1:李某某,男,52岁,火车司机。2003年6月20号初诊,血压低压100,高压 160,体状肥胖,血脂3.7,经常熬夜。开始服用降脂降压药茶一个月,到7月21号血压降 到低压90高压140。然后继续服用50天,血脂降到0.21。低高压参加体检一切正常。
病历2:王女士,女,农民,山区养猪大户。每天劳动量大,体质差、比较弱,长年头晕失眠,家务活干得很少。于2004年3月10号初到诊所检查血压,低压98高压190,开始 试服降压茶一月后,于2004年4月10号,低压降到92,高压降到145。后来连须服用了几 个月,现在低高压80-120,头也不痛不晕,睡眠良好、心情非常乐观,能参加一切农活及家 务。
病历3:董某某,男,33岁,工人。身强力壮、爱吃肥肉能喝酒,饮食无节制,休息无规律。2004年8月3号初诊,面红目赤、失眠、胃胀饮食无味。经中西药调理后,低压100 高压160。于2004年初服降脂降压药茶一月后低压降到了80高压降到138,血脂由原先的 3.6降到了0.20。目前酒量控制在3两半,工作不上夜班生活有规律了,每年体检各项化验 结果均正常。
病历4:王某某,男,52岁,农民。2013年10月12号来诊所就医。患者头晕、恶心、 偏头痛、耳鸣,血压70-170。用药治疗按照颈动脉供血不足,配合降脂降压药茶一周,10月 19号低压降到60、高压150,西药停服。继续服用降脂降压药茶一月后,低高压全降为正常 值,能按时参加正常的体力劳动。头痛、头晕,恶心都不存在。
病例5:余某某,男,72岁,铁路给水所职工。2014前后曾多次住院治疗,血糖血压忽高忽低。2014年12月初诊,当时血糖7.6,低压85高压170,身体虚弱不能行走,眼白内 障基本失明,乙丧失劳动能力,整天需家人培护。2013年12月6号服用降脂降压药茶2月, 低压稳定在80,高压降到了138。视力有所改变,血糖从原来的7.6恢复到5.5左右,但还 是不能自理。
病例6:段某某,男,58岁,工务段汽车司机。长年夜班,野外工作,身强力壮。2015年10月初诊,三高症,低压100高压178,血糖7点,血脂5.6。能吃能喝,当时尿少、频 尿、下肢浮肿,用西药调理、配合降压茶。到2015年11月16号服降脂压茶一月余,血压正 常,血糖血脂降低不理想,继续服用降脂降压药茶3个月,经检查三高全部达到正常值。内 心再也没有那么大的压力了,现在血压平稳健康良好。
Claims (3)
1.一种新配方、降脂降压药茶,其特征在于;他是由下列药物重量份组成的。绞股兰13-16份、木灵芝12-16份、西洋参10-16份、黄芪12-16份、制首乌10-16份、川芎10-16份、丹参8-12份、三七参8-12份、炒枣仁10-16份、
炒山药10-16份、草明6-10份、粉葛根10-16份、砂仁6-12份、炒白术10-16份、茯苓6-12份、炒意仁6-12份、天麻6-12份、僵蚕6-10份、勾藤6-12份、罗卜麻8-12份、夏枯球6-12份、霍山石斛6-12份、银杏叶6-10份、焦山楂10-12份、野菊花6-12份、桅枝6-10份、人参8-12份、抗菊6-12份、淫阳霍6-12份。
2.根据权利要求;1所述的降脂降压药茶、其特征在于;他是有下列重量份的药物加工制成的:
绞股篮12份、木灵芝10份、黄芪10份、西洋参8份、制首乌8份、川芎7份、丹参6份、三七参7份、炒枣仁8份、炒山药7份、草决明5份、粉葛根7份、砂仁6份、炒白术7份、茯芩6份、炒意仁6份、天麻6份、僵蚕5份、勾藤5份、罗卜麻叶6份、夏故球6份、霍山石斛5份、银杏叶6份、焦山楂7份、野菊花5份、桅枝5份、人参7份、抗菊5份、5份,权利要求将1.2所述的仝氏健安降脂降压药茶:春夏清肝-号药茶去掉;西洋参、野菊花、栀枝,加上人参、抗菊花、淫阳霍,为秋冬平稳降压=号。
3.根据权利要求:1.2任意所述的,降脂降压药茶与其制备方法,包括以下步骤:1权利要求将1.2所述的降脂降压药茶其包括药物份量及药物重量份,筛选无虫蛀、无霉烂、无变貭、色泽纯正药材地道将单味药物或多味药物混合在一起用电烤箱低温干燥后、以所述的重量份配比、用粉碎机进行加工粉碎、用200-300目筛选,得到的混合药粉后密闭存方备用,随后分装成密封袋,即茶袋。根据患者血压、血脂、血糖高低酌情掌握用量,用保温杯带茶冲温服,煎几分钟更好、常用量3~6克,每天一至二次冲服。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711120133.2A CN109793867B (zh) | 2017-11-14 | 2017-11-14 | 降脂降压药茶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711120133.2A CN109793867B (zh) | 2017-11-14 | 2017-11-14 | 降脂降压药茶 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109793867A true CN109793867A (zh) | 2019-05-24 |
CN109793867B CN109793867B (zh) | 2022-07-05 |
Family
ID=66554663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711120133.2A Expired - Fee Related CN109793867B (zh) | 2017-11-14 | 2017-11-14 | 降脂降压药茶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109793867B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113768007A (zh) * | 2020-06-10 | 2021-12-10 | 王敏 | 一种减肥降脂降压降糖的养生茶 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229312A (zh) * | 2007-01-23 | 2008-07-30 | 凌泰祥 | 一种具有调节高血压、高血脂及心绞痛的药物组合物 |
CN101401601A (zh) * | 2006-10-18 | 2009-04-08 | 吴建生 | “降三高(血压、血脂、血糖)”五叶仙茶 |
CN101428110A (zh) * | 2008-09-27 | 2009-05-13 | 钱修平 | 参降脂胶囊 |
CN102940801A (zh) * | 2012-11-08 | 2013-02-27 | 西安福安创意咨询有限责任公司 | 一种治疗高血压的中药组合物 |
CN103494188A (zh) * | 2013-09-03 | 2014-01-08 | 陈翔 | 一种降血脂纯中药溶剂 |
CN104645091A (zh) * | 2013-11-25 | 2015-05-27 | 陕西康乐中医药养生研究院 | 一种治疗高血压的胶囊 |
CN105560551A (zh) * | 2016-02-24 | 2016-05-11 | 任玥欣 | 用于治疗高血脂疾病的中药组合物及其制作方法 |
-
2017
- 2017-11-14 CN CN201711120133.2A patent/CN109793867B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101401601A (zh) * | 2006-10-18 | 2009-04-08 | 吴建生 | “降三高(血压、血脂、血糖)”五叶仙茶 |
CN101229312A (zh) * | 2007-01-23 | 2008-07-30 | 凌泰祥 | 一种具有调节高血压、高血脂及心绞痛的药物组合物 |
CN101428110A (zh) * | 2008-09-27 | 2009-05-13 | 钱修平 | 参降脂胶囊 |
CN102940801A (zh) * | 2012-11-08 | 2013-02-27 | 西安福安创意咨询有限责任公司 | 一种治疗高血压的中药组合物 |
CN103494188A (zh) * | 2013-09-03 | 2014-01-08 | 陈翔 | 一种降血脂纯中药溶剂 |
CN104645091A (zh) * | 2013-11-25 | 2015-05-27 | 陕西康乐中医药养生研究院 | 一种治疗高血压的胶囊 |
CN105560551A (zh) * | 2016-02-24 | 2016-05-11 | 任玥欣 | 用于治疗高血脂疾病的中药组合物及其制作方法 |
Non-Patent Citations (2)
Title |
---|
刘荣东等: "加味半夏白术天麻汤对痰湿壅盛型代谢综合征的影响", 《中华中医药学刊》 * |
王尚清等: "自拟"降脂饮"治疗高脂血症及合并症", 《内蒙古医学院学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113768007A (zh) * | 2020-06-10 | 2021-12-10 | 王敏 | 一种减肥降脂降压降糖的养生茶 |
Also Published As
Publication number | Publication date |
---|---|
CN109793867B (zh) | 2022-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860969A (zh) | 一种增肥的中药 | |
CN107126485A (zh) | 一种辅助改善睡眠的中药组合物及其制备方法和应用 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN103041209B (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
CN107952040A (zh) | 用于调理气郁体质的中药膏方及其加工方法 | |
CN104069390A (zh) | 一种用于增肥的中药汤剂 | |
CN103405636B (zh) | 一种治疗失眠的药物及其制备方法 | |
CN104958646A (zh) | 一种润肠通便的中药制剂及其制备方法 | |
CN102772780A (zh) | 一种治疗失眠的药物及其制备方法 | |
CN108355088A (zh) | 一种改善睡眠质量的酸枣仁药酒及其制备方法 | |
CN102266052A (zh) | 一种具有改善睡眠功能的保健食品 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN105343865A (zh) | 一种治疗神经性呕吐的药物及其制备方法 | |
CN109793867A (zh) | 降脂降压药茶 | |
CN109224021A (zh) | 治疗糖尿病、降血压、降血脂的保健养生茶及制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN112316066A (zh) | 一种含茉莉花的安神助眠中药配方红糖及其制备方法 | |
CN1323598A (zh) | 抗疲劳胶囊 | |
CN104758431A (zh) | 改善心律不齐的片剂及其制备方法 | |
CN104825777A (zh) | 一种具有补气安神功效的保健胶囊及制备方法 | |
CN110420313A (zh) | 一种阿胶人参饮品的生产工艺及其方法 | |
CN103705733A (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
CN102960728A (zh) | 一种食疗养生组合物 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 | |
CN102250736A (zh) | 一种保健药酒及其制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220705 |